-
公开(公告)号:US20060024336A1
公开(公告)日:2006-02-02
申请号:US11095918
申请日:2005-03-30
申请人: Dominique Charmot , John Fordtran , Han Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
发明人: Dominique Charmot , John Fordtran , Han Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
IPC分类号: A61K9/00
CPC分类号: A61K9/1635 , A61K9/5026 , A61K9/5031 , A61K31/74 , A61K45/06
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
-
公开(公告)号:US20050220889A1
公开(公告)日:2005-10-06
申请号:US10813872
申请日:2004-03-30
申请人: Dominique Charmot , John Fordtran , Han Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
发明人: Dominique Charmot , John Fordtran , Han Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
IPC分类号: A61K9/50
CPC分类号: A61K9/5031 , A61K9/5026 , A61K9/5047
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
摘要翻译: 本发明提供了用于治疗离子失衡的方法和组合物。 特别地,本发明提供了核 - 壳组合物及其药物组合物。 本文公开了用于治疗和/或预防益处的核 - 壳组合物的使用方法。 这些方法的实例包括治疗磷酸盐不平衡障碍,高血压,慢性心力衰竭,终末期肾病,肝硬化,慢性肾功能不全,流体过载或钠过载。
-
公开(公告)号:US20050220890A1
公开(公告)日:2005-10-06
申请号:US10814749
申请日:2004-03-30
申请人: Dominique Charmot , John Fordtran , Han Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
发明人: Dominique Charmot , John Fordtran , Han Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
CPC分类号: A61K9/5031 , A61K9/5026 , A61K9/5047
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
-
公开(公告)号:US07854924B2
公开(公告)日:2010-12-21
申请号:US10814527
申请日:2004-03-30
申请人: Robert Alpern , Jerry Buysse , Han Ting Chang , Dominique Charmot , Michael James Cope , John Fordtran , Gerrit Klaerner , Eric Connor , Mingjun Liu , Futian Liu , Jun Shao
发明人: Robert Alpern , Jerry Buysse , Han Ting Chang , Dominique Charmot , Michael James Cope , John Fordtran , Gerrit Klaerner , Eric Connor , Mingjun Liu , Futian Liu , Jun Shao
CPC分类号: A61K31/74
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium-binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
-
公开(公告)号:US07429394B2
公开(公告)日:2008-09-30
申请号:US11095918
申请日:2005-03-30
申请人: Dominique Charmot , John Fordtran , Han Ting Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
发明人: Dominique Charmot , John Fordtran , Han Ting Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
CPC分类号: A61K9/1635 , A61K9/5026 , A61K9/5031 , A61K31/74 , A61K45/06
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
摘要翻译: 本发明提供了用于治疗离子失衡的方法和组合物。 特别地,本发明提供核 - 壳组合物及其药物组合物。 本文公开了用于治疗和/或预防益处的核 - 壳组合物的使用方法。 这些方法的实例包括治疗磷酸盐失衡障碍,高血压,慢性心力衰竭,终末期肾病,肝硬化,慢性肾功能不全,流体过载或钠过量。
-
公开(公告)号:US08282960B2
公开(公告)日:2012-10-09
申请号:US10813872
申请日:2004-03-30
申请人: Dominique Charmot , John Fordtran , Han Ting Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
发明人: Dominique Charmot , John Fordtran , Han Ting Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
CPC分类号: A61K9/5031 , A61K9/5026 , A61K9/5047
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
-
公开(公告)号:US07776319B2
公开(公告)日:2010-08-17
申请号:US11095760
申请日:2005-03-30
申请人: Robert Alpern , Jerry Buysse , Han Ting Chang , Dominique Charmot , Michael James Cope , John Fordtran , Gerrit Klaerner , Eric Connor , Mingjun Liu , Futian Liu , Jun Shao
发明人: Robert Alpern , Jerry Buysse , Han Ting Chang , Dominique Charmot , Michael James Cope , John Fordtran , Gerrit Klaerner , Eric Connor , Mingjun Liu , Futian Liu , Jun Shao
IPC分类号: A61K31/74 , A61K31/765 , A61K31/785 , A61K9/14 , A61P3/12 , A61P9/12 , A61P13/12
CPC分类号: A61K31/78 , A61K9/14 , A61K9/1635 , A61K9/5026 , A61K9/5031 , A61K31/74 , A61K31/785 , A61K31/795 , A61K31/80 , A61K45/06 , C08F120/06 , C08F128/02 , Y10S514/838 , Y10S514/869 , Y10S514/87 , Y10S514/893
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium-binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
摘要翻译: 本发明提供了用于治疗离子失衡的方法和组合物。 特别地,本发明提供了包含钠结合聚合物及其药物组合物的组合物。 本文公开了用于治疗和/或预防益处的聚合物和药物组合物的使用方法。 这些方法的实例包括治疗高血压,慢性心力衰竭,终末期肾病,肝硬化,慢性肾功能不全,流体过载或钠过载。
-
公开(公告)号:US08192758B2
公开(公告)日:2012-06-05
申请号:US10814749
申请日:2004-03-30
申请人: Dominique Charmot , John Fordtran , Han Ting Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
发明人: Dominique Charmot , John Fordtran , Han Ting Chang , Eric Connor , Mingjun Liu , Gerrit Klaerner
IPC分类号: A61K9/14
CPC分类号: A61K9/5031 , A61K9/5026 , A61K9/5047
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides core-shell compositions and pharmaceutical compositions thereof. Methods of use of the core-shell compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of phosphate imbalance disorders, hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.
摘要翻译: 本发明提供了用于治疗离子失衡的方法和组合物。 特别地,本发明提供了核 - 壳组合物及其药物组合物。 本文公开了用于治疗和/或预防益处的核 - 壳组合物的使用方法。 这些方法的实例包括治疗磷酸盐不平衡障碍,高血压,慢性心力衰竭,终末期肾病,肝硬化,慢性肾功能不全,流体过载或钠过载。
-
公开(公告)号:US08216560B2
公开(公告)日:2012-07-10
申请号:US12055726
申请日:2008-03-26
申请人: Dominique Charmot , Han Ting Chang , John Fordtran , Gerrit Klaerner , Jerry M. Buysse , Robert Alpern , Mingjun Liu
发明人: Dominique Charmot , Han Ting Chang , John Fordtran , Gerrit Klaerner , Jerry M. Buysse , Robert Alpern , Mingjun Liu
IPC分类号: A61K31/74
CPC分类号: A61K31/78 , A61K9/14 , A61K9/1635 , A61K9/5026 , A61K9/5031 , A61K31/74 , A61K31/785 , A61K31/795 , A61K31/80 , A61K45/06 , C08F120/06 , C08F128/02 , Y10S514/838 , Y10S514/869 , Y10S514/87 , Y10S514/893
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.
摘要翻译: 本发明提供了用于治疗离子失衡的方法和组合物。 特别地,本发明提供了包含钾结合聚合物及其药物组合物的组合物。 本文公开了用于治疗和/或预防益处的聚合物和药物组合物的使用方法。 这些方法的实例包括治疗高钾血症,例如由肾衰竭引起的高钾血症和/或使用引起高钾血症的药物。
-
公开(公告)号:US20080241092A1
公开(公告)日:2008-10-02
申请号:US12055726
申请日:2008-03-26
申请人: Dominique Charmot , Han-Ting Chang , John Fordtran , Gerrit Klaerner , Jerry M. Buysse , Robert Alpern , Mingjun Liu
发明人: Dominique Charmot , Han-Ting Chang , John Fordtran , Gerrit Klaerner , Jerry M. Buysse , Robert Alpern , Mingjun Liu
CPC分类号: A61K31/78 , A61K9/14 , A61K9/1635 , A61K9/5026 , A61K9/5031 , A61K31/74 , A61K31/785 , A61K31/795 , A61K31/80 , A61K45/06 , C08F120/06 , C08F128/02 , Y10S514/838 , Y10S514/869 , Y10S514/87 , Y10S514/893
摘要: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.
-
-
-
-
-
-
-
-
-